The scientific community has turned to a promising near-term solution to treat COVID-19: use of antibody drugs. There are several companies, including Regeneron, that are developing this kind of approach. The biotech company's president and chief scientific officer Dr. George Yancopoulos joins "CBS Evening News" with more.
